An increasing number of consumers in the Czech Republic are reducing their consumption of systemic analgesics in favour of topical alternatives, which are perceived to be a safer option for self-medication. The gradual shift from systemic analgesics towards topical analgesics/anaesthetic is set to continue over the forecast period as consumers increasingly opt for healthier lifestyles and try to limit their intake of systemic drugs.
Paediatric analgesics are largely purchased for children suffering from acute short-term illnesses such as fever, moderate pain or ear infections, and parents seek a gentle solution to relieve their discomfort. Generally, oral suspension is preferred for infants, whilst suppositories and tablets are more convenient to use for older children.
After a flat average retail value performance over the review period, adult aspirin returned to moderate growth in 2019, largely driven by innovation in packaging, increasing marketing efforts and the strong performance of private label products, which entered the category in 2017. Brands also innovated in adult aspirin, further renewing interest in these products.
Sanofi retained its strong lead in analgesics in 2019 despite the withdrawal of Ibalgin Baby due to the suspicion that a foreign substance may be present in a specific batch, which had been on the market since mid-October 2018. It has been estimated that about 1,660 drug packages had been circulated to pharmacies or patients.
The former GlaxoSmithKline and Pfizer are joining forces in OTC with the announcement of a joint venture. The new OTC business is expected to have revenues of approximately GBP9.
New product development in analgesics is limited, focusing mainly on new faster-acting variants of existing brands. However, the leading pharmacy chain, Ceska Lekarna Holding, (Dr Max) introduced its Parapyrex Combi private label line in 2018 to replace its existing Paracetamol Dr Max.
You have no recently viewed reports.
Why not browse through our Featured or Trending Reports to see what we have to offer?
Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Czech Republic with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Analgesics industry in Czech Republic, our research will save you time and money while empowering you to make informed, profitable decisions.
The Analgesics in Czech Republic market research report includes:
Our market research reports answer questions such as:
Why buy this report?
This industry report originates from Passport, our Consumer Health market research database.